— Know what they know.
Not Investment Advice

PKI NYSE

PerkinElmer, Inc.
1W: +5.3% 1M: -10.8% 3M: -6.6% 1Y: -17.8% 3Y: +30.8% 5Y: +59.5%
$115.24
Last traded 2023-05-23 — delisted
NYSE · Healthcare · Medical - Diagnostics & Research · $14.5B mcap · 116M float · 0.699% daily turnover

Balance Sheet Trends

Total Assets
$12.2B -1.8% ▼
5Y CAGR: +8.7%
Total Liabilities
$4.9B +4.1% ▲
5Y CAGR: +2.8%
Shareholders Equity
$7.3B -5.4% ▼
5Y CAGR: +14.2%
Cash & Investments
$920M -20.9% ▼
5Y CAGR: +18.0%
Total Debt
$3.4B +2.0% ▲
5Y CAGR: +9.1%
Net Debt
$2.4B +14.5% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$618M$454M$913M$1.2B$920M
Short-Term Investments$0$0$690M$0$0
Cash & ST Investments$618M$454M$1.6B$1.2B$920M
Net Receivables$1.0B$613M$633M$632M$745M
Inventory$625M$405M$428M$368M$379M
Other Current Assets$174M$122M$337M$186M$196M
Total Current Assets$2.4B$3.3B$3.0B$2.3B$2.2B
Property, Plant & Equip.$753M$671M$665M$650M$645M
Goodwill & Intangibles$11.5B$9.9B$9.6B$9.1B$9.0B
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$342M$299M$343M$288M$323M
Total Non-Current Assets$12.6B$10.8B$10.6B$10.0B$9.9B
Total Assets$15.0B$14.1B$13.6B$12.4B$12.2B
— Liabilities —
Accounts Payable$355M$273M$204M$167M$185M
Short-Term Debt$4M$471M$722M$242K$589M
Deferred Revenue$304M$136M$0$0$0
Other Current Liabilities$567M$687M$524M$485M$557M
Total Current Liabilities$1.2B$1.6B$1.5B$653M$1.3B
Long-Term Debt$5.2B$4.1B$3.3B$3.3B$2.8B
Other Non-Current Liab.$9M$1.4B$0$0$0
Total Non-Current Liabilities$6.7B$5.2B$4.2B$4.1B$3.6B
Total Liabilities$7.9B$6.7B$5.7B$4.7B$4.9B
— Equity —
Common Stock$126M$126M$123M$121M$112M
Retained Earnings$4.4B$5.0B$5.6B$5.8B$6.1B
Accumulated OCI-$163M-$447M-$277M-$396M-$222M
Total Stockholders Equity$7.1B$7.4B$7.9B$7.7B$7.3B
Total Liabilities & Equity$15.0B$14.1B$13.6B$12.4B$12.2B
— Key Metrics —
Total Debt$5.2B$4.6B$4.0B$3.3B$3.4B
Net Debt$4.6B$4.1B$3.1B$2.1B$2.4B
Total Investments$0$0$690M$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms